Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

10/17/08 The chances of developing a malignant tumour are “significantly increased” for people who use a mobile for ten years.        

10/17/08 Experience with irinotecan for the treatment of malignant glioma        

10/17/08 Sagopilone crosses the blood-brain barrier in vivo to inhibit brain tumor growth and metastases        

10/17/08 Monmouth Medical Center art exhibit features original artwork created by kids and teens affected by a loved one’s brain tumor        

10/09/08 Free tickets to NY Islanders and Virtualtrials.com is moving!        

10/08/08 Target Acquired: It may become possible to vaccinate against brain tumours        

10/06/08 Urbana quilt project raises money for brain cancer research        

10/06/08 UCSF surgeon changes study of brain tumors        

10/04/08 Proton Radiation Appears to Lower Risk for Secondary Cancers        

10/04/08 Efficacy of a phase II vaccine targeting Cytomegalovirus antigens in newly diagnosed GBM.        

10/04/08 Prospective phase II trial for recurrent high-grade gliomas with capacitive coupled low radiofrequency (LRF) hyperthermia.        

10/04/08 A phase II trial with cetuximab, bevacizumab, and irinotecan for patients with primary glioblastomas and progression after radiation therapy and temozolamide.        

10/04/08 Phase I/II study of cetuximab plus temozolomide as radiochemotherapy for primary glioblastoma (GERT)        

10/04/08 Role of a second chemotherapy in recurrent malignant glioma patients who progress on a bevacizumab-containing regimen.        

10/04/08 A phase II, randomized, non-comparative clinical trial of the effect of bevacizumab (BV) alone or in combination with irinotecan (CPT) on 6-month progression free survival (PFS6) in recurrent, treatment-refractory glioblastoma (GBM).        

10/04/08 Effect of EGFRvIII-targeted vaccine (CDX-110) on immune response and TTP when given with simultaneous standard and continuous temozolomide in patients with GBM.        

10/04/08 Phase II trial of talampanel in conjunction with standard radiation (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM).        

10/04/08 Update on survival from the original phase II trial of bevacizumab and irinotecan in recurrent malignant gliomas.        

10/04/08 Phase II study of bevacizumab and etoposide in patients with recurrent malignant glioma.        

---

Displaying Stories 3381 to 3400 of 7673
Previous 20           Next 20